Navigation Links
Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
Date:12/3/2008

and advancing our preclinical pipeline, while maintaining a strong balance sheet. We have established important commercial agreements in the non-therapeutic aspects of our technology with Dow Agrosciences in plant agriculture and Sigma-Aldrich Corporation in research reagents. We also have agreements with Genentech and Pfizer in cell-line engineering. We plan to establish strategic partnerships around our therapeutic programs at points of value inflection and expect 2009 to be another year of significant accomplishments for Sangamo."

Mr. Lanphier continued, "We are pursuing a broad development program for our lead ZFP Therapeutic(TM), SB-509, an activator of vascular endothelial growth factor (VEGF) with three Phase 2 clinical trials ongoing for the treatment of diabetic neuropathy (DN) and one to evaluate its use in the treatment of amyotrophic lateral sclerosis (ALS). We have also advanced our preclinical pipeline and expect to file Investigational New Drug (IND) application for the first of our ZFN-based therapeutic programs for HIV/AIDS before the end of 2008.

"We are very pleased by the progress of our non-therapeutic collaborations this year. Our partner Sigma-Aldrich successfully launched the CompoZr brand of ZFN-based gene editing tools and we look forward to the increased interest and further validation of the technology that this broadening of the user-base will bring. We also transitioned ahead of schedule into the commercial phase of our collaboration with Dow AgroSciences (DAS) to apply our ZFP technology for plant agriculture and expect DAS to begin to sublicense the technology in that industry. The success of these activities is key to further enhancing the market-leading presence for our technology. We believe that our progress in advancing our technology platform, which is unique in its generation of novel, highly differentiated therapies and products, will create interest among potential pharmace
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
2. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
3. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
7. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
8. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
11. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 A lot of discussion ... methods for treating  certain illnesses, injuries, or conditions. As medical ... previous treatment methods with ones that they consider to be ... there is not one textbook method of treatment that stands ...
(Date:1/23/2015)... 23, 2015  A new analysis of Centers for Medicare ... data shows that 81 percent of seniors chose lower-cost ... discounts at certain pharmacies. The findings were released by ... are now the foundation of Medicare Part D," said ...
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... 2011 The U.S. Food and Drug Administration today ... implement during 2011 to improve the most common path ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Key actions include: ... innovative, lower-risk medical devices, Clarifying when clinical data ...
... Throughout the playoffs and championship game of Professional Football, ... play at winning TemporalScanner™ Temporal Artery Thermometers. Football fans ... announced on national radio broadcasts of pro football,s divisional ... win an Exergen TemporalScanner. The "Exergen ...
Cached Medicine Technology:FDA to Improve Most Common Review Path for Medical Devices 2Exergen 'Game Time Temperature' Contest Helps Football Fans Tackle Cold and Flu Season 2Exergen 'Game Time Temperature' Contest Helps Football Fans Tackle Cold and Flu Season 3
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... 2015 IsoComforter, Inc. has introduced the most ... IsoTube design to treat specific body parts and muscle groups. ... and easy to use patented cold therapy machine with the ... orthopedic and muscle injuries. IsoComforter has become the industry ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list ... policy . , Some types of vehicles cannot be covered ... released blog post to see if their vehicle qualifies for auto ... some of the cars that cannot be covered by a plan. ...
(Date:1/22/2015)... 2015 State Forestry Institute of Mecklenburg-Vorpommern ... with support from GEOSYSTEMS, a dedicated Hexagon Geospatial and ... leverage Hexagon Geospatial’s ERDAS APOLLO for cataloging, ... as point clouds and documents. This effort will enable ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... Baxano, Inc. today,announced the addition of Tony Recupero ... and Marketing. Mr. Recupero, a well known industry,executive, is ... to an impressive procedural growth and revenue ramp during ... announcement, Jeff Bleich, CEO and founder of Baxano,said, "Over ...
... issued study that found retail pharmacy workers are exposed ... airborne pharmaceutical agents needs further review -, DREXEL, ... statement today regarding serious concerns about efforts,by McKesson/Parata to ... face when they work in pharmacies using air,pressure driven ...
... Search engine for medical professionals honored for second ... the leading,search engine for medical professionals, today announced ... Association. SearchMedica was named Best,Directory or Search Engine., ... and in the last year we continued incorporating ...
... Health Care Heroes, HARRISBURG, Pa., Nov. 10 ... to build tomorrow,s health care,workforce by showcasing eight ... Week., "This special week helps put middle ... that will benefit millions of,Pennsylvanians," said Governor Rendell. ...
... Program to offer expansive list of benefits for 4D ... ... announced a new partnership with 4D Pharmacy Management Systems, Inc.,that will greatly ... The announcement was made today by Mark,Murray, President of the Grand Rapids, ...
... 10 Medicaid Health Plans of,America (MHPA), the ... plans, today joined the chorus of noted,organizations calling ... economic,stimulus package this session that includes additional funding ... Harry Reid and Mitch McConnell, Speaker,Nancy Pelosi and ...
Cached Medicine News:Health News:Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers 2Health News:Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers 3Health News:SearchMedica.com Earns 2008 WebAward: Best Directory or Search Engine 2Health News:SearchMedica.com Earns 2008 WebAward: Best Directory or Search Engine 3Health News:Governor Rendell Shines Health Careers Week Spotlight on 8 In-Demand Occupations 2Health News:Governor Rendell Shines Health Careers Week Spotlight on 8 In-Demand Occupations 3Health News:Meijer and Prescription Benefit Manager 4D Team Up to Create Innovative Prescription Insurance Program 2Health News:Meijer and Prescription Benefit Manager 4D Team Up to Create Innovative Prescription Insurance Program 3Health News:Medicaid Health Plans of America Urges Congress to Pass Economic Recovery Package This Session Featuring Additional Funding for Medicaid 2
Curved delicate 5 mm blades....
... tissue forceps "micro 2000", ... spring tension light-weight instruments ... handles, extremely light weight, ... handle, fatigueless working, easy ...
Mini blades....
Operating microscope with motorized zoom and variable focus up to 405 mm....
Medicine Products: